These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1336845)

  • 21. [Differential diagnosis in hyperferritinemia].
    Olesnicki M
    Rev Med Brux; 2000 Dec; 21(6):A517-9. PubMed ID: 11194503
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemochromatosis and sexual dysfunction.
    Van deursen C; Delaere K; Tenkate J
    Int J Impot Res; 2003 Dec; 15(6):430-2. PubMed ID: 14671662
    [No Abstract]   [Full Text] [Related]  

  • 23. Iron depletion, deficiency and overload.
    Pollycove M
    West J Med; 1986 Nov; 145(5):684-5. PubMed ID: 3798917
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ferritin in serum].
    Zuyderhoudt FM
    Ned Tijdschr Geneeskd; 1982 Sep; 126(38):1733-7. PubMed ID: 7144933
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ferritin - determination and diagnostic significance].
    Fereberger W
    Wien Med Wochenschr; 1981 Oct; 131(20):493-6. PubMed ID: 7314630
    [No Abstract]   [Full Text] [Related]  

  • 26. Monocyte membrane ferritin in hemochromatosis.
    Adams PC; Flanagan PR; Chau L; White M; Lazarovits A
    Clin Invest Med; 1991 Oct; 14(5):402-8. PubMed ID: 1742918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary hemochromatosis.
    Holman JR
    J Fam Pract; 1997 Mar; 44(3):304-8. PubMed ID: 9071252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Editorial: Ferritinemia].
    Hershko C
    Harefuah; 1975 Jan; 88(2):80-1. PubMed ID: 1112560
    [No Abstract]   [Full Text] [Related]  

  • 29. Distinguishing hemophagocytic lymphohistiocytosis from hemochromatosis in patients with hyperferritinemia.
    Kapoor S
    Pediatr Blood Cancer; 2008 Jun; 50(6):1287; author reply 1287-8. PubMed ID: 18300323
    [No Abstract]   [Full Text] [Related]  

  • 30. Elevated serum ferritin levels: associated diseases and clinical significance.
    Olivé A; Juncà J
    Am J Med; 1996 Jul; 101(1):120; author reply 122. PubMed ID: 8686706
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hyper-ferritinemia and Gaucher disease].
    Laine F; Guyader D; Turlin B; Moirand R; Deugnier Y; Brissot P
    Gastroenterol Clin Biol; 1996; 20(5):512-3. PubMed ID: 8761155
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience.
    Hann HW; Evans AE; Siegel SE; Wong KY; Sather H; Dalton A; Hammond D; Seeger RC
    Cancer Res; 1985 Jun; 45(6):2843-8. PubMed ID: 3986811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 16189 Mitochondrial variant and iron overload.
    Salvador M; Villegas A; Llorente L; Ropero P; González FA; Bustamante L
    Ann Hematol; 2007 Jun; 86(6):463-4. PubMed ID: 17340136
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences between neuroblastoma stages IV-S and IV.
    N Engl J Med; 1981 Dec; 305(23):1418-9. PubMed ID: 7300864
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma ferritin concentrations: their clinical significance and relevance to patient care.
    Valberg LS
    Can Med Assoc J; 1980 Jun; 122(11):1240-8. PubMed ID: 6992966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radioimmunological detection of ferritin with the 'solid-phase' method].
    Reller H
    Pathol Microbiol (Basel); 1971; 37(3):201-14. PubMed ID: 5165349
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myocardiopathy caused by iron deposition. Treatment with chelating agents].
    Rodríguez Reguero JJ; Iglesias Cubero G; Espolita Santos A; López de la Iglesia JM; Enríquez Martín J; Tomás Mauri J; López-Negrete L
    Rev Esp Cardiol; 1985; 38(5):356-7. PubMed ID: 4081244
    [No Abstract]   [Full Text] [Related]  

  • 38. Haemochromatosis: the need for an agreed case definition.
    Patch C; Roderick P; Rosenberg W
    J Hepatol; 2005 Nov; 43(5):911. PubMed ID: 16171894
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitory effects of isoferritins from tumour and non-tumour tissues on E-rosette formation.
    Hann HW; Stahlhut MW; Chung LC
    Lancet; 1984 Jan; 1(8367):43. PubMed ID: 6140361
    [No Abstract]   [Full Text] [Related]  

  • 40. Threshold limit value of subtilisins.
    Chien PT
    Am Ind Hyg Assoc J; 1977 Jul; 38(7):350. PubMed ID: 900018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.